ICCT Stock Price, iCoreConnect, Inc. Quote, Chart

Market Summary

USD1.16+0.01

Delayed

0.87%

ICCT Stock Price

View Fullscreen

ICCT RSI Chart

ICCT Valuation

Market Cap

10.1M

Price/Earnings (Trailing)

-1.34

Price/Sales (Trailing)

1.31

EV/EBITDA

-7.42

Price/Free Cashflow

-5.16

ICCT Price/Sales (Trailing)

ICCT Profitability

Operating Margin

97.22%

EBT Margin

-45.44%

Return on Equity

-8.38%

Return on Assets

-116.22%

Free Cashflow Yield

-19.38%

ICCT Fundamentals

ICCT Revenue

Revenue (TTM)

7.6M

ICCT Earnings

Earnings (TTM)

-7.4M

Breaking Down ICCT Revenue

Last 7 days

-11.5%

Last 30 days

-3.3%

Last 90 days

-21.1%

How does ICCT drawdown profile look like?

ICCT Financial Health

Current Ratio

0.11

ICCT Investor Care

Shares Dilution (1Y)

14.48%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	7.8M	7.6M	0	0
2022	6.3M	7.3M	7.8M	8.0M
2021	5.9M	6.4M	7.3M	5.0M
2020	1.2M	1.4M	1.7M	5.7M
2019	1.0M	1.1M	1.0M	1.0M
2018	848.2K	873.0K	1.0M	1.1M
2017	0	653.0K	621.4K	658.1K
2015	589.4K	0	0	0
2014	222.8K	366.4K	443.2K	503.9K
2013	228.1K	105.7K	164.0K	183.8K
2012	791.3K	595.5K	473.1K	350.6K
2011	0	438.1K	578.7K	640.3K
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of iCoreConnect, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Sep 14, 2023	shah archit	acquired	992	5.64	176	cfo
Jul 01, 2023	gitto joseph	acquired	-	-	97,983	-
Jul 01, 2023	travis harry joseph	acquired	-	-	262,506	-
Jul 01, 2023	mcdermott robert p	acquired	-	-	291,492	ceo & president
Jul 01, 2023	shah archit	acquired	-	-	145,746	cfo
Jul 01, 2023	mcdermott kevin patrick	acquired	-	-	196,880	-
Apr 14, 2023	chakravarthi muralidar	acquired	-	-	100,000	cto
Apr 14, 2023	fidanza david a.	acquired	-	-	200,000	cio
Apr 14, 2023	shah archit	acquired	-	-	200,000	cfo
Apr 11, 2023	stellinga jeff wayne	acquired	-	-	200,000	coo

Which funds bought or sold ICCT recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	MORGAN STANLEY	added	318,000	19,398	19,404	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	11.26	547	6,328	-%
May 15, 2024	TWO SIGMA SECURITIES, LLC	sold off	-100	-26,366	-	-%
May 15, 2024	Mariner, LLC	unchanged	-	-476	29,068	-%
May 14, 2024	Skaana Management L.P.	unchanged	-	165	168	-%
May 14, 2024	Qube Research & Technologies Ltd	unchanged	-	-32.00	1,952	-%
May 14, 2024	NewEdge Advisors, LLC	unchanged	-	-4.00	244	-%
May 14, 2024	SRS Capital Advisors, Inc.	unchanged	-	-	20.00	-%
May 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	added	15.38	8,756	73,539	-%
May 13, 2024	FMR LLC	new	-	622	622	-%

Are Funds Buying or Selling ICCT?

Are funds buying ICCT calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ICCT

No. of Funds

Peers (Alternatives to iCoreConnect, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

iCoreConnect, Inc. News

Latest updates

iCoreConnect, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Revenue	0.9%	1,856,148	1,840,371	2,044,084	1,888,768	2,011,161	2,043,889	1,906,063	1,365,112	981,378	704,001	4,226,212	530,000	472,000	506,000	204,000	225,000	305,000	280,000	195,500	271,000	272,000
Gross Profit	1.7%	1,372,115	1,348,922	1,574,004	1,371,108	1,389,878	1,409,659	1,254,348	944,197	713,650	463,968	309,744	256,000	262,000	287,000	146,000	142,000	229,000	192,000	105,000	141,000	150,000
Operating Expenses	28.9%	3,480,703	2,699,980	3,100,448	2,438,273	2,601,822	2,406,212	2,606,487	1,693,488	1,254,585	1,109,085	1,251,074	975,000	1,095,000	1,032,000	1,315,500	931,000	938,000	904,000	740,000	706,000	1,672,000
S&GA Expenses	32.3%	3,189,103	2,411,071	2,809,085	2,151,651	2,261,577	2,032,357	2,030,050	1,342,531	1,003,870	856,388	1,022,014	746,000	870,000	809,000	1,125,000	741,000	770,000	797,000	633,000	606,000	1,573,000
EBITDA Margin	0.4%	-0.18	-0.18	-0.17	-0.15	-0.17	-0.23	-0.31	-0.27	-0.32	-0.36	-0.40	-1.38	-1.74	-	-	-	-	-	-	-	-
Interest Expenses	5.0%	270,770	257,913	224,011	216,523	189,183	155,689	143,005	97,551	92,526	167,797	90,820	79,000	34,000	35,000	80,500	109,000	47,000	-49,000	-117,000	-59,000	-56,000
Earnings Before Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-719,000	-833,000	-745,000	-1,169,500	-789,000	-709,000	-712,000	-635,000	-565,000	-
EBT Margin	-2.0%	-0.45	-0.45	-0.43	-0.44	-0.47	-0.55	-0.70	-0.48	-0.54	-0.58	-0.60	-2.02	-2.51	-	-	-	-	-	-	-	-
Net Income	-60.3%	-2,707,595	-1,689,034	-1,648,486	-1,401,976	-1,487,127	-1,542,235	-1,462,271	-1,105,763	-1,583,233	-812,914	-1,080,241	-774,000	-857,000	-780,000	-722,000	-744,000	-756,000	-761,000	-696,000	-616,000	-1,578,000
Net Income Margin	-22.0%	-0.98	-0.80	-0.76	-0.75	-0.76	-0.90	-1.00	-0.63	-0.66	-0.59	-0.61	-1.83	-2.21	-	-	-	-	-	-	-	-
Free Cashflow	24.2%	-904,796	-1,192,984	398,543	-240,747	-431,423	-1,095,267	-1,014,159	-701,659	-	-	-	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-8.6%	6,408	7,007	6,556	6,747	7,235	8,184	6,630	7,405	5,708	4,230	2,752	2,691	2,590	2,587	2,715	2,522	2,287	2,355	1,873	1,735	2,246
Current Assets	-33.5%	1,119	1,683	1,092	1,036	1,266	1,916	1,013	1,365	1,212	-	420	154	227	198	210	554	238	213	351	234	719
Cash Equivalents	-91.4%	69.00	803	196	163	164	810	72.00	699	846	27.00	194	8.00	76.00	12.00	445	445	31.00	-	139	1.00	477
Net PPE	83.1%	200	109	74.00	80.00	86.00	92.00	93.00	51.00	15.00	-	2.00	2.00	3.00	-	-	6.00	7.00	-	9.00	11.00	10.00
Goodwill	0%	1,485	1,485	1,485	1,485	1,485	1,485	491	3,074	1,291	798	491	361	491	491	491	361	-	-	-	-	-
Liabilities	10.6%	10,635	9,620	9,058	8,661	8,018	7,815	5,625	5,314	3,359	2,767	2,176	3,320	2,609	2,382	2,162	2,057	1,999	2,807	2,722	2,693	2,940
Current Liabilities	33.4%	9,879	7,407	6,799	6,344	3,568	4,099	4,054	2,511	3,284	-	2,041	3,185	2,328	2,103	2,046	1,936	1,832	2,608	2,521	2,523	2,716
Long Term Debt	-100.0%	-	1,431	1,449	-	-	-	-	-	-	-	-	-	129	183	13.00	13.00	47.00	53.00	42.00	55.00	97.00
LT Debt, Current	-100.0%	-	5,041	4,280	-	-	-	-	-	965	-	965	1,429	1,286	1,058	908	880	1,285	1,275	1,305	1,361	1,606
LT Debt, Non Current	-100.0%	-	1,431	1,449	-	-	-	-	-	-	-	-	-	129	183	13.00	13.00	47.00	53.00	42.00	55.00	97.00
Shareholder's Equity	-	-	-	-	-	-	369	1,005	2,092	2,350	-	576	-	-	205	553	465	288	-	-	-	-
Retained Earnings	-3.0%	-93,271	-90,564	-88,875	-87,226	-85,824	-84,337	-82,795	-81,332	-80,227	-	-78,643	-77,831	-76,751	-75,977	-75,120	-74,340	-73,618	-72,874	-72,118	-71,344	70,648
Additional Paid-In Capital	1.2%	88,849	87,758	86,192	85,140	84,870	84,534	83,633	83,266	82,425	-	79,096	77,112	76,652	76,109	75,602	74,738	73,842	72,364	71,216	70,335	69,906
Shares Outstanding	1.1%	6,764	6,687	6,252	5,946	5,947	5,938	5,776	5,490	5,228	4,293	4,293	3,106	2,618	2,408	-	-	-	-	-	-	-
Float	-	-	-	-	-	9,700	-	-	-	9,700	-	-	-	-	9,700,000,000	-	-	-	9,576	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2
Cashflow From Operations	33.4%	-767	-1,152	403	-240	-385	-1,049	-968	-696	-715	-715	-128	-362	-436	-436	-175	-735	-383	-374	-388	-597	-503
Share Based Compensation	-	-	-	-	-	-	-	-	-	-	-	-	48.00	-	-	-	134	134	208	132	75.00	2,609
Cashflow From Investing	-62.7%	-315	-194	-93.02	-71.05	-66.60	-63.30	-125	-2,362	-48.68	-48.68	-107	89.00	-556	-556	-125	-90.00	-164	-94.00	-91.00	-90.00	-82.00
Cashflow From Financing	-82.2%	349	1,954	-276	310	-193	1,851	466	3,145	950	950	168	505	608	608	714	856	408	606	3.00	1,069	680
Buy Backs	-	-	-	-	-	45.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

About iCoreConnect, Inc.

iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.

CEO	Mr. Robert P. McDermott
WEBSITE	icoreconnect.com
INDUSTRY	Healthcare Plans
EMPLOYEES	41

iCoreConnect, Inc. Frequently Asked Questions

What is the ticker symbol for iCoreConnect, Inc.? What does ICCT stand for in stocks?

ICCT is the stock ticker symbol of iCoreConnect, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of iCoreConnect, Inc. (ICCT)?

As of Fri May 17 2024, market cap of iCoreConnect, Inc. is 10.15 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ICCT stock?

You can check ICCT's fair value in chart for subscribers.

What is the fair value of ICCT stock?

You can check ICCT's fair value in chart for subscribers. The fair value of iCoreConnect, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of iCoreConnect, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ICCT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is iCoreConnect, Inc. a good stock to buy?

The fair value guage provides a quick view whether ICCT is over valued or under valued. Whether iCoreConnect, Inc. is cheap or expensive depends on the assumptions which impact iCoreConnect, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ICCT.

What is iCoreConnect, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, ICCT's PE ratio (Price to Earnings) is -1.34 and Price to Sales (PS) ratio is 1.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ICCT PE ratio will change depending on the future growth rate expectations of investors.